These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10160473)

  • 1. Cost effectiveness and the allocation of therapies in a treating population.
    Langley PC
    Pharmacoeconomics; 1996 Jul; 10(1):93-8. PubMed ID: 10160473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis.
    Robinson R
    BMJ; 1993 Sep; 307(6907):793-5. PubMed ID: 8219957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Expected Costs and Benefits of Granting Access to New Treatments on the Basis of Progression-Free Survival in Non-Small-Cell Lung Cancer.
    Lakdawalla DN; Chou JW; Linthicum MT; MacEwan JP; Zhang J; Goldman DP
    JAMA Oncol; 2015 May; 1(2):196-202. PubMed ID: 26181023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of economic analyses in U.S. managed care formulary decisions: a private payer's experience.
    Watkins JB; Minshall ME; Sullivan SD
    J Manag Care Pharm; 2006; 12(9):726-35. PubMed ID: 17249905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and effects in lumbar spinal fusion. A follow-up study in 136 consecutive patients with chronic low back pain.
    Soegaard R; Christensen FB; Christiansen T; Bünger C
    Eur Spine J; 2007 May; 16(5):657-68. PubMed ID: 16871387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental health care system optimization from a health-economics perspective: where to sow and where to reap?
    Lokkerbol J; Weehuizen R; Mavranezouli I; Mihalopoulos C; Smit F
    J Ment Health Policy Econ; 2014 Jun; 17(2):51-60. PubMed ID: 25153093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy evaluation, patient distribution, and cost-outcomes ratios.
    Langley PC
    Clin Ther; 1995; 17(2):341-7. PubMed ID: 7614534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dedicated Perioperative Hip Fracture Comanagement Programs are Cost-effective in High-volume Centers: An Economic Analysis.
    Swart E; Vasudeva E; Makhni EC; Macaulay W; Bozic KJ
    Clin Orthop Relat Res; 2016 Jan; 474(1):222-33. PubMed ID: 26260393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost-effectiveness analysis of first-line controller therapies for persistent asthma.
    Shih YC; Mauskopf J; Borker R
    Pharmacoeconomics; 2007; 25(7):577-90. PubMed ID: 17610338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serving patient needs while implementing cost effectiveness programs in health care administration.
    Tootelian DH
    Health Mark Q; 1994; 11(3-4):161-73. PubMed ID: 10137013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of treatments for high-risk myelodysplastic syndromes after failure of first-line hypomethylating agent therapy.
    Cogle CR; Ortendahl JD; Bentley TG; Anene AM; Megaffin S; McKearn TJ; Petrone ME; Mukherjee S
    Expert Rev Pharmacoecon Outcomes Res; 2016; 16(2):275-84. PubMed ID: 26589773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment costs, equilibrium, and the allocation of patients to therapy alternatives.
    Langley PC; Bhattacharyya SK
    Clin Ther; 1997; 19(4):830-6. PubMed ID: 9377625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of short-term psychodynamic psychotherapy and solution-focused therapy in the treatment of depressive and anxiety disorders during a one-year follow-up.
    Maljanen T; Paltta P; Harkanen T; Virtala E; Lindfors O; Laaksonen MA; Knekt P;
    J Ment Health Policy Econ; 2012 Mar; 15(1):13-23. PubMed ID: 22611089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles of cost effectiveness analysis for the assessment of current and new therapies.
    Hillner BE; Smith TJ; Desch CE
    J Hematother; 1993; 2(4):501-6. PubMed ID: 8087498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of treating multidrug-resistant tuberculosis.
    Resch SC; Salomon JA; Murray M; Weinstein MC
    PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.